EICHOR
● Completed
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
Condition: KRAS p, G12c Mutated /Advanced Metastatic NSCLC · Sponsor: Amgen
About this study
A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (274)
| Pacific Cancer Medical Center Inc | Anaheim, California, United States | — |
| City of Hope National Medical Center | Duarte, California, United States | — |
| Pacific Shores Medical Group Long Beach | Long Beach, California, United States | — |
| University of California Los Angeles | Los Angeles, California, United States | — |
| University of California Los Angeles | Los Angeles, California, United States | — |
| University of California at Davis Medical Center | Sacramento, California, United States | — |
| Ridley Tree Cancer Center | Santa Barbara, California, United States | — |
| University of California San Francisco Mission Hall | Stanford, California, United States | — |
| Harbor University of California Los Angeles Medical Center | Torrance, California, United States | — |
| Rocky Mountain Cancer Centers | Denver, Colorado, United States | — |
| Danbury Hospital | Norwalk, Connecticut, United States | — |
| Medical Oncology Hematology Consultants Helen F Graham Cancer Center | Newark, Delaware, United States | — |
+ 262 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04303780